You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023136011
Dec 202394010
Jan 20243904
Feb 20244207
Mar 20242002
Apr 202412019
May 20241004
Jun 20242001
Jul 2024803
Aug 2024803
Sep 20242402
Oct 20242003
Nov 20241406
Dec 2024604
Jan 202516010
Feb 2025404
Mar 2025003
Apr 2025006
May 2025004
Jun 2025005
Total4730111